25/07/2025
Last week, the FDA convened a panel to revisit the black box warning on vaginal estrogen, a label that’s contributed to confusion, stigma, and decades of under-treatment.
This didn’t happen in a vacuum. It’s the result of persistent, tireless advocacy from clinicians, researchers, patients, and policy voices who’ve been pushing to get menopause care the attention it deserves.
Dr. Corinne Menn has a 2-minute breakdown of what happened and why it matters. Worth the watch and a share with anyone navigating this stage of life or supporting someone who is.